0001956559-23-000001.txt : 20231218 0001956559-23-000001.hdr.sgml : 20231218 20231218164810 ACCESSION NUMBER: 0001956559-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 EFFECTIVENESS DATE: 20231218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rezo Therapeutics, Inc. CENTRAL INDEX KEY: 0001956559 ORGANIZATION NAME: IRS NUMBER: 874039235 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-466228 FILM NUMBER: 231494433 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH STREET 2: SUITE 525 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-310-4524 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH STREET 2: SUITE 525 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D/A 1 primary_doc.xml X0708 D/A LIVE 0001956559 Rezo Therapeutics, Inc. 455 MISSION BAY BOULEVARD SOUTH SUITE 525 SAN FRANCISCO CA CALIFORNIA 94158 415-310-4524 DELAWARE None None Corporation true 2021 Nadir Mahmood C/O REZO THERAPEUTICS, INC. 455 MISSION BAY BOULEVARD SOUTH, STE 525 SAN FRANCISCO CA CALIFORNIA 94158 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b true 0001956559-22-000001 2022-07-21 true true false 0 80129936 46348088 33781848 This filing covers the sale and purchase of Series A Preferred Stock, and the Common Stock issuable upon conversion thereof. false 20 0 0 0 false Rezo Therapeutics, Inc. Nadir Mahmood Nadir Mahmood Chief Executive Officer 2023-12-18